Nicotinic modulation of mesoprefrontal dopamine neurons: Pharmacologic and neuroanatomic characterization

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 1, 2000, Pages 58-66

  George, Tony P ^a   Verrico, Christopher D ^a   Picciotto, Marina R ^a   Roth, Robert H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; OPIATE PEPTIDE; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHANNEL GATING; CIGARETTE SMOKING; COMORBIDITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; NEUROANATOMY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RATING SCALE; SCHIZOPHRENIA; VENTRAL TEGMENTUM;

ANIMALS; DIHYDRO-BETA-ERYTHROIDINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MECAMYLAMINE; NICOTINIC ANTAGONISTS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 0033816068     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Nicotine's opioid and anti-opioid interactions: Proposed role in smoking behavior
2. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices
3. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders
4. Nicotine cue: Lack of effect of the α7 nicotinic receptor antagonist methyllycaconitine
5. Autoradiographic evidence of nicotine receptors on nigrostriatal and mesolimbic dopamine neurons
6. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
7. Effects of repeated nicotine pretreatment on mesoprefrontal dopaminergic and behavioral responses to acute footsheck stress
8. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress: Evidence for opioid mechanisms
9. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: A behavioral, neuroendocrine, and neurochemical study in the rat
10. Immunocytochemical localization of a neuronal nicotinic receptor: The β2 subunit
11. The role of mesoprefrontal dopamine neurons in stress
12. Prevalence of smoking among psychiatric outpatients
13. Nicotine-haloperidol interactions and cognitive performance in schizophrenics
14. Protein measurement with the phenol-folin reagent
15. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
16. Prior exposure to cocaine diminishes behavioral and biochemical responses to aversive conditioning: Reversal by glycine/NMDA antagonist co-treatment
17. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory in rate and monkeys
18. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area
19. Nicotine dependence, midbrain dopamine systems and psychiatric disorders
20. Nicotine withdrawal in the rat: Role of α7 nicotinic receptors in the ventral tegmental area
21. Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate- and aspartate-induced currents in horizontal cells dissociated from catfish retina
22. Common aspects of the action of nicotine and other drugs of abuse
23. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
24. Nicotine activates and desensitizes midbrain dopamine neurons
25. Antidepressant effect of transdermal nicotine patches in non-smoking patients with major depression
26. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: Putative role of α7 nicotinic receptors in the ventral tegmental area
27. Selective antagonism of behavioral effects of nicotine by dihydro-β-erythroidine in rats
28. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: Effects of acute and repeated injections
29. Binding of the nicotinic cholinergic antagonist, dihydro-beta-erythroidine, to rat brain tissue
30. Nicotinic acetylcholine receptors in separate brain regions exhibit different affinities for methyllycaconitine
31. Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues
32. Developmental regulation of nicotinic receptor subunit mRNAs in the rat central and peripheral nervous systems